Liberty Defense (SCAN.V) (LDDFF) Is Positioning To Disrupt A Multi-Billion Dollar Industry
There have been more mass shootings this year in the United States than there have been days in the year. Over 330 mass shootings , to be exact. This is becoming a huge issue that is costing precious lives and could see billions of dollars spent to fix this situation.
One company has a technology product that could disrupt this multi-billion-dollar industry for the better. And not just all of the countless lives saved – but investors too could benefit. How? To first understand this, you need to grasp the sheer scope of this market.
Global spending on security solutions is projected to reach $7.4 billion in 2019 and increase to over $11.3 billion by 2025 with a CAGR of 8.2%. The urban Security explosives and Weapons Detection market is slated to grow to nearly $7.5 billion by 2025 and is forecast to see consistent growth for the next several years .
What does this mean? Well, for investors it could signal big opportunities but with so many large companies targeting surveillance systems and weapon detection devices as a “go-to,” is there anything that could truly disrupt this market?
In short, yes
Liberty Defense (SCAN.V) (LDDFF) Is Positioning To Change The Face Of Threat Detection For Good
The truth of the matter is that mass shootings now happen more than once a day in the US and as we’ve come to find, there’s no real way to stop these attacks after an attacker enters a space. This is where the real opportunity is: stopping an attack before someone even enters a vulnerable space.
Liberty Defense (TSX: SCAN.V) (OTC: LDDFF) plans to do that using HEXWAVE, a next-generation high-tech security scanning system that will use advanced, low-power radar, 3D-imaging, and Artificial Intelligence (AI) to screen people at public gatherings such as sports games, unobtrusively.
The advanced attack prevention system can detect if someone is armed before they enter a building using radar energy and Artificial Intelligence (AI) to detect weapons and explosives in real-time. You may be thinking that the processes and screening technology that you see in airports can achieve the same thing in our communities. But we’re talking about urban detection; where high people traffic flow and attempts to provide airport-like screening processes can be extremely disruptive to business activity because of security entry delays.
As important to providing a higher rate of threat screening is that there also needs to be a way to detect other potential mass attack weapons including explosives, pyrotechnics and other non-metallic threats.
What Sets Liberty Defense (SCAN.V) (LDDFF)’s HEXWAVE Apart From The Competition?
HEXWAVE is the first practical application of real-time, 3D imaging. It uses low-power radar energy, which helps generate real-time 3D images to detect weapons such as guns, knives, explosives, and other threats through clothing, backpacks and hand baggage. This product creates, real-time concealed threat images which are assessed using deep learning and AI. Thus alerting security regarding the decision response hierarchy.
HEXWAVE – A Product Integrating A New Wave of Technology
- Detects metallic and non-metallic threat objects in real time
- Designed for indoor/outdoor use
- Covert and overt installation
- AI/deep learning for threat and anomaly detection
- The modular, mobile system design enables HEXWAVE units to be placed at facility perimeters or quickly redeployed where needed for a layered defense
- Can be used stand-alone or combined with other security measures including video management, lock-out systems and command centers
- Environmental immunity, unaffected by temperature, EMI, proximity to metal, etc.,
HEXWAVE provides enhanced security options without disrupting the flow of daily life by scanning quickly and unobtrusively. This is key to catching threats in real time. This is ideal for use in high traffic areas and a huge leap forward from the traditional metal detector.
Liberty Defense (SCAN.V) (LDDFF) will be Testing In Real Life Scenarios!
The demand is present and Liberty Defense (TSX: SCAN.V) (OTC: LDDFF) has already inked several Memorandums of Understanding for beta testing of HEXWAVE, which is expected to start in early 2020! This initially included Vancouver Area Limited Partnership’s Rogers Arena, and Sleiman Enterprises, one of Florida’s largest real estate companies developing and managing malls, hotels, and shopping centers, Liberty Defense (TSX: SCAN.V) (OTC: LDDFF) has created a strong pipeline of premier potential customers.
The opportunity to test with Vancouver Arena Limited Partnership in or around Roger’s Arena could present a big opportunity to prove HEXWAVE and the technology. The arena itself has hosted over 25 million fans and is home to myriad events.
That opportunity alone would be something huge for a company in beta phases. But this HEXWAVE product has captured attention across North America appearing on Fox, The Wall Street Journal and countless other, top-tier media outlets. The attention has been so great that the company also has earned deals to beta test HEXWAVE with the likes of:
- FC Bayern München sports club based in Bavaria
- The Virginia Division of Capitol Police; and
- The Office of the Utah Attorney General
HEXWAVE uses low-power, radar 3D imaging and artificial intelligence, primarily to detect and identify weapons, as well as other threats and anomalies. It enables security teams to detect these threats at the perimeter of a property without obstructing the movement of large groups of people. By extending the detection space and widening the perimeter, HEXWAVE enables a layered defense strategy, which provides security teams with a longer time horizon to manage threats.
Liberty Secures Its Place with NVIDIA’s AI Program
Beta testing with such big names isn’t an easy feat but Liberty Defense (TSX: SCAN.V) (OTC: LDDFF) has taken things a step even further. The company has been accepted into NVIDIA’s AI program built specifically to accelerate growth for AI technology.
For a company of this size to earn such a position speaks volumes about the potential that HEXWAVE could hold. The virtual accelerator program provides tools, technology, and expertise to help Liberty Defense (TSX: SCAN.V) (OTC: LDDFF) during the stages of product development, prototyping, and deployment. It also offers training from the NVIDIA DL institute, hardware discounts, and grants.
Liberty Defense (SCAN.V) (LDDFF)’s Opportunities Ahead For Detection
Emerging companies in this sector are poised for increased opportunities and growth with the political spotlight looking at gun control and public safety. This technology product could revolutionize the standards of security and set Liberty Defense (TSX: SCAN.V) (OTC: LDDFF) up to become a market leader taking a seat at the table with companies like major government contractor L3 Technologies (LLL) who provides detection and security systems for U.S. Department of Defense, Homeland Security. Similarly, it could position itself to directly take on tech innovators like Harris Corp. (HRS), which supports government and commercial customers in over 100 countries.
“Currently, there is a significant gap that must be addressed in urban security threat defense. HEXWAVE provides a wider perimeter for early detection beyond just the point solution typically positioned at an entrance of a facility. This essential layer will enable security measures to be proactively deployed to detect a threat before it transitions to an attack condition. Liberty Defense (TSX: SCAN.V) (OTC: LDDFF) can fill this gap.”Bill Riker, CEO of Liberty Defense (TSX: SCAN.V) (OTC: LDDFF).
Liberty Defense (SCAN.V) (LDDFF)’s All-Star Management
Advancement from the operational to strategic level is a crucial undertaking that all companies must undergo in pursuit of success. The executive leadership team at Liberty Defense (TSX: SCAN.V) (OTC: LDDFF) has the necessary insight to achieve profitable growth and maintain operational systems.
Bill Riker, Chief Executive Officer
Bill Riker, the company’s chief executive officer, joined Liberty Defense (TSX: SCAN.V) (OTC: LDDFF) in August 2018. Since then, Riker has played a key role in establishing the company as an industry leader in the urban security market. Prior to joining the Liberty Defense (TSX: SCAN.V) (OTC: LDDFF) leadership team, Riker racked up over three decades of extensive experience in the defense and security industry, including executive roles in the Department of Defense, General Dynamics, DRS Technologies and Smiths Detection which focused on threat detection solutions, and identification of chemical, radiological, nuclear and explosive threats for the global security market.
Aman Bhardwaj, President of U.S. Operations & Chief Operating Officer
Liberty Defense (TSX: SCAN.V) (OTC: LDDFF)’s President Of U.S. Operations and Chief Operating Officer, Aman Bhardwaj is a product development and operations executive with over 25 years of experience in bringing consumer electronics products and services to market in mobile phone, Smart TV, and e-learning industries. Mr. Bhardwaj has built and led global teams in the U.S., Canada, China, and India for large multi-national and start-up companies such as Panasonic, Flextronics, Educo, and Hisense. Mr. Bhardwaj holds both a Bachelor and Master of Science Degree in Electrical Engineering from Georgia Institute of Technology, specializing in RF and Electromagnetics. He also received an Executive MBA from Georgia State University and is currently pursuing a Doctorate in Business Administration from Northcentral University.
Bart Smudde, Chief Technology Officer
Liberty Defense (TSX: SCAN.V) (OTC: LDDFF) chief technology officer, Bart Smudde, brings over 30 years of experience to the table in designing, testing and manufacturing electronics products in several markets including military and medical. Smudde has managed engineering teams for companies including Graco, Landis+Gyr, SignalONE Safety, and Panasonic.
Ron Solanki, VP Operations of U.S, Subsidiary, Liberty Defense Technologies Inc.
In early May, 2019, Liberty Defense (TSX: SCAN.V) (OTC: LDDFF) brought on Ron Solanki as VP Operations of its US Subsidiary. Mr. Solanki has held leadership positions with major multi-national global electronics corporations such as Motorola, Panasonic, Flextronics and Hisense. With over 30 years of experience delivering results in high-tech company operations, he has helped build businesses around strategic business management and development, R&D, manufacturing, supply chain, and legal affairs. He has also served on international boards of directors and business & technology advisory boards.
Jordan Eck, VP of Implementation and Service
Jordan Eck is a senior executive with 15 years of experience building and leading skilled technical resource teams across national and international territories. He has an established record of successful sales and operational initiatives with an emphasis on corporate-wide strategic and tactile results targeting organizational alignment, operational efficiency, high-energy/performance culture, and customer experience. With over 2000+ successful projects in his portfolio, Jordan has lead initiatives for stakeholders including the U.S. Government, U.S. Military, DISA, and various fortune 500 organizations. Jordan is a trained system engineer for multiple forms of electronic, physical, and network security platforms. Jordan holds advanced degrees in Project Management, Corporate Finance, and Organizational Leadership.
Robert (Bob) Falk, VP of Sales and Business Development
Mr. Falk has over 20 years of experience in the detection and security inspection industries as well as in business development and sales. Mr. Falk served as Evolv Technology’s Director of International Sales, and has also worked as an independent aviation security consultant for a number of U.S. and European companies including Gilardoni, AS&E and Surescan.
Key Board Appointments Can Secure Additional Opportunities
While management is key, so are the people on its board and advisors. These members can, and in the case of Liberty Defense (TSX: SCAN.V) (OTC: LDDFF), HAVE led the company to even more opportunities and market insight. It doesn’t take long to connect the dots:
- Jeremy Morton, Executive Chairman, Corporate Strategy Officer of Minimax Viking. Previously President of Stanley Access Technologies. Held senior roles at Stanley Local Security, CNL Software, Ingersoll Rand, and Schneider Electric.
- John McCoach, Lead Independent Director, Past President of the TSXV (9 years). Board member of the Capital Markets Authority Implementation Organization
- Corby Marshall, a
- Francesco Aquilini, NHL Governor
- Victor Montagliani, VP of FIFA
- Anthony T. Sleiman, CEO and President of Sleiman Enterprises, Inc., one of Florida’s largest privately held real estate companies.
- Craig Peters, one of the top CBRE brokers in the Western US.
- Al Grasso, former President and CEO of The MITRE Corporation; and
- Mit Shah, founder and CEO of Noble Investment Group.
Can You Detect A Winner?
We live in a world where threats to our safety, both large and small, have impacted the way we live. Increased security measures are being taken in several aspects of daily life such as entering a school or even a baseball game. Worse off, not all current security measures are stopping these threats before they happen.
The Global spending on security solutions is projected to reach $7.4 billion in 2019 and increase to over $11.3 billion by 2025 with a CAGR of 8.2%. The urban Security explosives and Weapons Detection market is slated to grow to nearly $7.5 billion by 2025 with infrastructure surveillance leading the charge as we said above! 
Liberty Defense (TSX: SCAN.V) (OTC: LDDFF) is working on a solution to combat these issues head-on through the implementation of its HEXWAVE product. As we move towards the future, it important for investors to pay attention to his sector and Liberty Defense (TSX: SCAN.V) (OTC: LDDFF) could have the key to disrupting a multi-billion dollar industry!
 Homeland Security Research Corp (HSRC) for Explosives & Weapons Detection Systems Technologies & Industry 2018-2025
Alibaba (BABA) Stock Price Signaling Buy Or Sell After The Recent Surge?
China has grown into the world’s second-largest economy over the past few decades. One Chinese company that mirrors the remarkable growth of the country is Alibaba Group Holding Ltd – ADR (NYSE:BABA). The e-commerce behemoth is rightly called the ‘Amazon of China’ and it has grown at a remarkable pace over the past two decades.
However, Jack Ma, who oversaw the company’s rise has decided to depart. Most analysts believe that Alibaba stock is still a buy despite this development. There are several factors to consider, however.
Jack Ma may have departed but the robust business model that he has created is still in place. That will likely continue to help drive the company’s growth. The Alibaba marketplace is massive and it allows Chinese companies to sell abroad, while at the same time allowing domestic consumers to sell to each other.
Sales Continue To Drive Margins
On mobile devices alone, the company recorded as many as 755 million monthly active users in China. On top of e-commerce, Alibaba has also branched into a tech company. It has its own cloud service known as Alibaba Cloud and has also created its own payments platform Alipay. Alipay already boasts of as many as 600 million users.
Moreover, despite trade tensions with the United States, the Chinese economy is expected to grow over the next decade and expand the size of the middle class. China is already the biggest market for e-commerce companies and the expanding middle class will continue to contribute towards its hyper-growth. Joseph Tsai, the company’s vice chairman stated that even smaller cities in China are expanding rapidly and that retail consumption would hit $7 trillion by 2030.
Last but not least, the company has consistently delivered impressive financial results and in the recent quarters, it has managed to beat analysts’ earnings estimates comfortably.
Stock Price Newsletter – September 23, 2019
3 Small-Cap Biotech Stocks To Watch In Coming Weeks
The fact that biotech companies often improve on existing treatments, makes them a far more attractive target for a range of investors. Here is a look at three biotech stocks to watch during the last few weeks of the quarter.
This Stock is Looking to Disrupt the Multi-Billion Dollar Defense Industry
Global spending on security solutions is projected to reach $7.4 billion in 2019 and increase to over $11.3 billion by 2025 with a CAGR of 8.2% and is forecast to see consistent growth for the next several years. What Could This Mean For ONE COMPANY?
Multi-Billion Dollar Markets Are Ready For A Shake-Up
There’s no denying that biotechnology is one of the hottest markets in the world. Right now a multi-billion-dollar segment is ready for a shakeup and one biotech stock could hold the secret to doing just that!
3 Small-Cap Biotech Stocks To Watch In Coming Weeks
Biotech has been one of the hottest sectors for investors for as long as it has existed and the reasons are self-evident. It is a sector that uses cutting edge technology and comes up with treatments for a wide range of diseases.
Moreover, the fact that biotech companies often improve on existing treatments, makes them a far more attractive target for a range of investors. Here is a look at three biotech stocks to watch during the last few weeks of the quarter.
PharmaCyte Biotech (PMCB)
There has been no lack of attention on biotech penny stocks this year. At the beginning of August, one small biotech stock broke to highs of over $10 from a starting price below $2 a share after releasing news. PharmaCyte Biotech (PMCB) focuses on ways to effectively deliver treatments to patients with diseases ranging from cancer to diabetes.
The company’s proprietary cellulose-based live-cell encapsulation technology known as “Cell-in-a-Box®is the platform that the company uses to develop its therapy delivery methods. For most of the quarter, shares of PMCB stock have traded between $0.033 and $0.04 with volume recently surging.
On September 19, PharmaCyte saw more than 6 million shares trade; well above its daily average. Most of the attention surrounding the company has been on two things. First, its progress with Cell-In-A-Box and the application for Pancreatic cancer has continued to progress. The company brought on Dr. Manuel Hidalgo, has confirmed that he will be Principal Investigator (PI) for PharmaCyte’s planned clinical trial in locally advanced, inoperable pancreatic cancer (LAPC) now that he is at Weill Cornell Medical Center.
What To Watch For
This week PharmaCyte (PMCB) will host a call designed to update all shareholders and the investment community simultaneously of material developments. The call will cover PharmaCyte’s preparations for submission of its Investigational New Drug application (IND) to the U.S. FDA to treat locally advanced, inoperable pancreatic cancer. It will also cover developments related to PharmaCyte’s product pipeline. PharmaCyte has been working on these and will discuss things not yet reported in a press release.
Catalyst Pharmaceuticals (CPRX)
The first one to watch is Catalyst Pharmaceuticals Inc (NASDAQ:CPRX). It is a small-cap stock engaged in developing medicines for rare diseases. Catalyst managed to get an approval for one of its products from the FDA earlier this year.
Since the approval of the Lambert-Eaton myasthenic syndrome (LEMS treating medicine Firdapse, Catalyst stock went on a massive rally from January to April. The approval of a rival drug halted the rally. Only after a civil suit from Catalyst did the stock stabilize somewhat.
Last week, Catalyst stock received a fresh boost after the company announced that it was going to make a secondary offering. However, the company decided to pull the offering the very next day and that affected the stock price once again.
What To Watch For
Analysts believe that pulling the secondary offering was the right long term decisions and this stock could be heading for another rally soon.
Eyepoint Pharmaceuticals (EYPT)
The biotech stock that could prove to be a major winner in the biotech sector this month is that of Eyepoint Pharmaceuticals Inc (NASDAQ:EYPT). There are two factors at play. The company revenues are going to rise significantly in the coming years due to the commercial launch of two medicines.
The first one is Yutiq, which is meant for the treatment of chronic non-infectious uveitis and the other one is Dexycu, which is meant for postoperative ocular inflammation.
What To Watch For
The company is currently trading at only double that of its future revenue and that is a very attractive multiple. EYPT stock has caught the attention of analysts on Wall Street. Guggenheim has set a 12-month target price of $4, which reflects 116% gains during the period.
Join Our Newsletter
Get stock alerts, news & trending stock alerts straight to your inbox!
We keep all user information pricate & promise to never spam.*
Search Stock Price (StockPrice.com)
Biotechnology2 weeks ago
This Biotech Stock Could Hold the Key to a Multi-Billion Dollar Market Shake-up
Featured1 week ago
Tiziana Life Sciences (TLSA) Announces FDA Approval to Initiate Phase I Clinical Trial with Orally Administered Foralumab in Healthy Volunteers
Biotechnology2 weeks ago
Multi-Billion Dollar Markets Are Ready For A Shake-Up; 1 Biotech Stock Could Hold The Key
Biotechnology2 weeks ago
Are Biotech Stocks Setting The Stage For Another Bull Trend?
Featured2 weeks ago
This Biotech Stock is Looking to Deliver Huge Positive Change
Featured7 days ago
Top 4 Penny Stocks To Watch This Week
Biotechnology2 weeks ago
Tiziana Reports Phase 1 Clinical Data Demonstrating Nasal Treatment with Foralumab was Well-tolerated and Produced Positive Trend in Biomarkers of Immunomodulation and Anti-inflammation in Healthy Volunteers
Biotechnology1 day ago
3 Small-Cap Biotech Stocks To Watch In Coming Weeks